Woodline Partners’s Carlsmed CARL Stock Holding History

Woodline Partners’s Portfolio CARL Stock Details CARL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,210	Closed	-$311K	–	1148
2025 Q3	$311K	Buy	+23,210	New	+$317K	﹤0.01%	856

Other funds holding CARL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Woodline Partners's CARL Position: Q4 2025 in Review

Woodline Partners sold out of Carlsmed (CARL) in Q4 2025, closing a stake of 23,210 shares — an estimated $311K sold.

Woodline Partners first reported a position in CARL in Q3 2025 and held it in 1 quarter. The position peaked at $311K in Q3 2025. 57 funds tracked by Wall St. Rank hold CARL as of Q4 2025.

Woodline Partners reported no remaining Carlsmed position as of Q4 2025 after selling out during the quarter.
Woodline Partners sold 23,210 Carlsmed shares in Q4 2025, an estimated $311K.
Woodline Partners first reported a position in Carlsmed in Q3 2025 and held it in 1 quarter.
Woodline Partners's Carlsmed position peaked at $311K in Q3 2025.
57 funds tracked by Wall St. Rank held Carlsmed as of Q4 2025.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.